This article was originally published on PharmaTimes http://www.pharmatimes.com/news/prep_impact_trial_to_double_in_size_1274817

Speed of recruitment and demand for a trial assessing the impact of HIV prevention therapy PrEP has significantly exceeded initial predictions, leading researchers to consider increasing the number of participants from 13,000 to up to 26,000.

Related Posts